Representative Michael C. Burgess (R-TX) has served Texas's 26th congressional district since 2003 and is a practicing physician who brought his medical expertise to Congress. As a former chairman of the House Energy and Commerce Subcommittee on Health, he's been a prominent voice on healthcare policy, Medicare reform, and medical innovation. Between October 2021 and July 2024, Burgess disclosed 64 stock transactions with an estimated volume between $456K and $1.9M, showing concentrated activity in healthcare and life sciences companies including Stryker (SYK), Illumina (ILMN), and AbbVie (ABBV), alongside positions in Blackstone (BX) and Amazon (AMZN). His trading activity has been notably quiet in recent months, with no disclosed transactions in the past 90 days, though his portfolio reflects his deep familiarity with the medical device and pharmaceutical sectors he oversees legislatively.
No buy trades found in this time window.
Try selecting a different range above.
Upgrade to PRO to see all 131 trades, detailed analysis, and advanced tools.
